Historical Background

Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group, the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA and now have grown to become nation's one of the leading pharmaceutical companies, supplying more than 10% of country's total medicine need. Today Beximco Pharma manufactures and markets its own `branded generics' for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes for both national and international markets.

Company profile
Beximco Pharma manufactures a range of dosage forms including tablets, capsules, dry syrup, powder, cream, ointment, suppositories, large volume intravenous fluids, metered dose inhalers etc. in several world-class manufacturing plants, ensuring high quality standards complying with the World Health Organization (WHO) approved current Good Manufacturing Practices (cGMP).They also contract manufacture for major international brands of leading multinational companies.

SWOT Analysis of BEXIMCO PHARMACEUTICALS: SWOT Analysis is a strategic planning method used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or project and identifying the internal and external factors that are favorable and unfavorable to achieving that objective.

: of

Strengths attributes the

organization those are helpful to achieving the objective. Weaknesses: attributes of the organization those are harmful to achieving the objective. Opportunities: external conditions those are helpful to achieving the objective.

Threats: external conditions which could do damage to the business's performance.

SWOT analysis of Beximco Pharma: Strength:

Large potential market Huge demand of mass people Public trust Availability of capital Low labor cost Employee Empowerment Capability to Bring Innovation & product differentiation Outstanding Product Quality World Class Professional Service

Weakness:
political instability lack of technology high illiteracy rate uncertainty in the country situation environmental hazards Insufficient Working Capital Not Operating in Low Cost Market.

Opportunities:
using ample resource using best manpower to develop a strong atmosphere in Asia increasing public demand Ability to Retain Growth & market Focus In difficult Operating Situations Ability to Exploit Opportunities of Patent Law as an LDC in International Market.

Threats:
vulnerable political situation instability in country situation globalization threats Strong Competitors in Domestic & International Market. Government & International Regulations. Rising Trend of Material Price